Related Experiment Video

Updated: Jul 16, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
08:02

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

5.5K

Glutamine availability unleashes dendritic cells' anti-tumor power

Mauro Corrado1, Christian Frezza2

  • 1University of Cologne, Faculty of Mathematics and Natural Sciences, Institute for Genetics, Cologne, Germany; Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.

Cell Chemical Biology
|September 22, 2023
PubMed

Insights

Cancer cells and immune cells compete for glutamine in the tumor microenvironment. This metabolic competition acts as a checkpoint, influencing anticancer immunity. Targeting glutamine metabolism may enhance cancer therapies.

Area of Science:

  • Oncology
  • Immunology
  • Metabolic pathways

Background:

  • Metabolic competition within the tumor microenvironment (TME) critically influences the effectiveness of anticancer immunity.
  • Understanding nutrient utilization by cancer and immune cells is key to developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of glutamine as an intercellular metabolic checkpoint between cancer cells and immune cells within the TME.
  • To evaluate the potential of targeting glutamine metabolism for improving anti-cancer therapies.

Main Methods:

  • The study by Guo et al. (Nature, August 3rd) investigated intercellular metabolic competition in the TME.
  • Analysis focused on the role of glutamine in mediating interactions between cancer and immune cells.

Main Results:

  • Glutamine was identified as a crucial intercellular metabolic checkpoint.
  • The availability and utilization of glutamine directly impact the efficacy of anticancer immune responses.

Conclusions:

  • Targeting glutamine metabolism represents a promising strategy to enhance the effectiveness of anti-cancer therapies.
  • Modulating glutamine availability in the TME could overcome metabolic resistance and boost anti-tumor immunity.

More Related Videos

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.3K
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551